Compound details
cis-p-Coumaroylcorosolic acid
| Compound ID | CDAMM02016 |
|---|---|
| Common name | cis-p-Coumaroylcorosolic acid | IUPAC name | 11-hydroxy-10-[3-(4-hydroxyphenyl)prop-2-enoyloxy]-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |
| Molecular formula | C39H54O6 |
| Retention time | 11.6 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 619.399 | Theoretical mz | 619.399 |
| Error | 0.61 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.6825 |
| Inchi key | FEVUQLLYZLSRLB-XNTDXEJSNA-N |
|---|---|
| Smiles | O=C(OC1C(O)CC2(C)C3CC=C4C5C(C)C(C)CCC5(C(=O)O)CCC4(C)C3(C)CCC2C1(C)C)C=CC6=CC=C(O)C=C6 |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P29350 | PTPN6 | Protein-tyrosine phosphatase 1C | T98264 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction and SEA |
| P17706 | PTPN2 | T-cell protein-tyrosine phosphatase | T49156 | SEA |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction and SEA |
| P13726 | F3 | Coagulation factor VII/tissue factor | T72702 | SEA |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SEA |
| O76083 | PDE9A | Phosphodiesterase 9A | T17852 | SwissTargetPrediction |
| Q01064 | PDE1B | Phosphodiesterase 1B | T77613 | SwissTargetPrediction and SEA |
| O43826 | SLC37A4 | Glucose-6-phosphate translocase | T47306 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T49156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P17706 | PTPN2 |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T72702 | DI0075 | Cervical cancer | [ICD-11: 2C77] | P13726 | F3 |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T17852 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O76083 | PDE9A |
| T17852 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | O76083 | PDE9A |
| T17852 | DI0165 | Genitourinary disease | [ICD-11: GA0Z-GC8Z] | O76083 | PDE9A |
| T17852 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | O76083 | PDE9A |
| T17852 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | O76083 | PDE9A |
| T17852 | DI0331 | Parkinsonism | [ICD-11: 8A00] | O76083 | PDE9A |
| T17852 | DI0370 | Schizophrenia | [ICD-11: 6A20] | O76083 | PDE9A |
| T17852 | DI0381 | Sickle-cell disorder | [ICD-11: 3A51] | O76083 | PDE9A |
| T77613 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q01064 | PDE1B |